cdmo.directory
← Compare landing

JYMed Peptide vs MyBiotech GmbH

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/jymedtech/mybiotech

CategoryJYMed PeptideMyBiotech GmbH
Listed sitecdmocdmo
SummaryPeptide CDMO offering custom synthesis from milligrams to metric tons, with 13 cGMP lines and FDA-, NMPA- and EDQM-approved sites. Provides peptide API manufacturing plus syringe, cartridge and lyophilized finished-dose filling at its Shenzhen site.Germany-based CDMO specializing in nanoparticle formulation, process development, GMP manufacturing, and aseptic fill-finish for nanomedicines and advanced drug delivery products.
Services
  • Peptide Manufacturing
  • API Synthesis & Manufacturing
  • Process Development
  • CMC Analytical Development
  • Formulation Development
  • Lyophilization (Freeze Drying)
  • Cartridge Filling
  • Prefilled Syringe (PFS) Filling
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Secondary Packaging & Labeling
  • Quality Control Testing
  • CMC Regulatory Submission Support
  • Formulation Development
  • Process Development
  • CMC Analytical Development
  • Stability Testing & Storage
  • Quality Control Testing
  • Lyophilization (Freeze Drying)
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Technology Transfer
  • CMC Regulatory Submission Support
Modalities
  • Peptide
Data not yet provided.
IndicationsData not yet provided.Data not yet provided.
Locations
  • Shenzhen headquarters, Shenzhen, Guangdong, China
  • Shenzhen R&D Center, Shenzhen, Guangdong, China
  • Shenzhen FDF manufacturing site, Shenzhen, Guangdong, China
  • Hubei API manufacturing site, Hubei, China
  • Headquarters, Überherrn, Saarland, Germany
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.